Aspartylglucosaminuria
Thomas Opladen(Heidelberg University), Georg F. Hoffmann(Heidelberg University), Hilal Al-Rifai(Hamad Medical Corporation), Ute Moog(Heidelberg University), Friedrich Ebinger(Defence Research and Development Organisation), Tawfeg Ben‐Omran(Qatar Airways (Qatar)), Inga Harting(Heidelberg University), Johannes Zschocke(Innsbruck Medical University), Peter Ruef(Boston Children's Hospital), Noora Shahbeck(Hamad Medical Corporation), Christine Fischer(Heidelberg University), Devjani Sengupta(Boston Children's Hospital), Friederike Bürger(Boston Children's Hospital), Dorothea Haas(Heidelberg University)
Cited by 14
Related Papers
The 2017 international classification of the Ehlers–Danlos syndromes
|American Journal of Medical Genetics Part C Seminars in Medical Genetics|2017|1.9k
Lomustine and Bevacizumab in Progressive Glioblastoma
|New England Journal of Medicine|2017|994
Nusinersen initiated in infants during the presymptomatic stage of spinal muscular atrophy: Interim efficacy and safety results from the Phase 2 NURTURE study
|Neuromuscular Disorders|2019|636